Feedback / Questions
liraglutide (4P004) - 4P-Pharma
https://www.businesswire.com/news/home/20260107798042/en/4Moving-Biotech-Receives-FDA-IND-Clearance-for-4P004-Strengthening-Its-Position-as-a-Leading-Innovator-in-Disease-Modifying-Osteoarthritis-Therapeutics
Jan 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next